POST Online Media Lite Edition


VolitionRx appoints David Vanston as CFO

Staff Writer |
Namur, Belgium - April 12, 2017, Namur, Belgium - VolitionRx, a life sciences company, announced that David Vanston joined Volition as its new chief financial officer.

Article continues below

Mr. Vanston brings with him a strong background as an international finance executive and a senior controller, including extensive experience in Sarbanes-Oxley compliance and implementation of successful change programs.

Mr. Vanston has worked in a variety of sectors from manufacturing and technology to life sciences, with globally-listed companies.

Mr. Vanston has 20 years of financial management experience.

He held positions as Vice President of Excorp Medical, an early-stage company, Chief Financial Officer for GrowHow and Vice President Europe, Finance for Monster Worldwide.

Mr. Vanston managed and oversaw the accounting, finance, tax, treasury, financial planning and analysis of the business.


Ectosense appoints Ciaran McCourt as chief executive officer
WABCO Holdings appoints Roberto Fioroni as CFO
Jacques Vandermeiren named CEO for Antwerp Port Authority
Michaël Trabbia appointed CEO of Orange Belgium
iSTAR Medical strengthens board with two senior appointments

What to read next

VolitionRx appoints Louise Day as chief marketing officer
VolitionRx appoints David Kratochvil as CFO
Omnitracs appoints David Vice as chief sales officer